• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于重编程类风湿关节炎微环境的信使纳米酶

Messenger Nanozyme for Reprogramming the Microenvironment of Rheumatoid Arthritis.

作者信息

Jia Ming, Ren Wei, Liu Yan, Wang Chenglong, Zheng Xiu, Zhang Dan, Tan Xiaoqiu, Li Chunhong

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan646000, China.

National Traditional Chinese Medicine Clinical Research Base and Drug Research Center of the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou646000, China.

出版信息

ACS Appl Mater Interfaces. 2023 Jan 11;15(1):338-353. doi: 10.1021/acsami.2c16458. Epub 2022 Dec 29.

DOI:10.1021/acsami.2c16458
PMID:36580409
Abstract

Dysregulation of superoxide anion (O) and hydrogen peroxide (HO) metabolism in the microenvironment of rheumatoid arthritis (RA) drives the feedback loops of TNF-α and IL-1β thereby inducing an inflammatory storm between immune cells and joint tissue cells. Here, we combine nanoscale manganese dioxide (MnO) with microvesicles derived from macrophage (MMV). The former possesses superoxide dismutase (SOD) and catalase (CAT)-like activities that can modulate this imbalance, and we amplify the enzyme-like activities by using the amorphous hollow mesoporous structure and surface modification. The latter is a natural endogenous component with the parent cell-like inflammatory homing ability and a unique function of transmitting information to surrounding and distant cells (″messenger function″), which helps amorphous hollow MnO (H-MnO) nanozymes to cloak in the blood and reach the site of inflammation, where they can not only accumulate in activated macrophages but also pretend to be ″messengers″ that are utilized by fibroblast-like synoviocytes (FLS) and chondrocytes. In addition, we also load dexamethasone sodium phosphate (DSP) for helping the nanozymes work. Messenger nanozyme (MMV-MnO@DSP) inherits the natural properties of MMV and mimics the enzymatic activity of SOD and CAT. It accumulates in activated macrophages to restore the metabolism of O and HO while promoting repolarization and inhibits the feedback loops of TNF-α and IL-1β among macrophages, fibroblast-like synoviocytes, and chondrocytes, leading to anti-rheumatoid arthritis effects in vitro and in vivo.

摘要

类风湿关节炎(RA)微环境中超氧阴离子(O)和过氧化氢(HO)代谢失调驱动肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)的反馈回路,从而在免疫细胞和关节组织细胞之间引发炎症风暴。在此,我们将纳米级二氧化锰(MnO)与巨噬细胞衍生的微囊泡(MMV)相结合。前者具有超氧化物歧化酶(SOD)和过氧化氢酶(CAT)样活性,可调节这种失衡,并且我们通过使用无定形中空介孔结构和表面修饰来增强酶样活性。后者是一种天然内源性成分,具有类似母细胞的炎症归巢能力以及向周围和远处细胞传递信息的独特功能(“信使功能”),这有助于无定形中空MnO(H-MnO)纳米酶在血液中伪装并到达炎症部位,在那里它们不仅可以在活化的巨噬细胞中积累,还能伪装成被成纤维样滑膜细胞(FLS)和软骨细胞利用的“信使”。此外,我们还负载地塞米松磷酸钠(DSP)以帮助纳米酶发挥作用。信使纳米酶(MMV-MnO@DSP)继承了MMV的天然特性,并模拟SOD和CAT的酶活性。它在活化的巨噬细胞中积累以恢复O和HO的代谢,同时促进极化并抑制巨噬细胞、成纤维样滑膜细胞和软骨细胞之间TNF-α和IL-1β的反馈回路,从而在体外和体内产生抗类风湿关节炎的作用。

相似文献

1
Messenger Nanozyme for Reprogramming the Microenvironment of Rheumatoid Arthritis.用于重编程类风湿关节炎微环境的信使纳米酶
ACS Appl Mater Interfaces. 2023 Jan 11;15(1):338-353. doi: 10.1021/acsami.2c16458. Epub 2022 Dec 29.
2
Genistein inhibit cytokines or growth factor-induced proliferation and transformation phenotype in fibroblast-like synoviocytes of rheumatoid arthritis.染料木黄酮抑制类风湿关节炎成纤维样滑膜细胞中细胞因子或生长因子诱导的增殖和转化表型。
Inflammation. 2012 Feb;35(1):377-87. doi: 10.1007/s10753-011-9365-x.
3
Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.肥大细胞活化及其与类风湿性病变中促炎细胞因子产生的关系。
Arthritis Res. 2000;2(1):65-74. doi: 10.1186/ar70.
4
Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway.白藜芦醇通过调节 PI3K/Akt 通路抑制 TNF-α诱导的人类风湿关节炎成纤维样滑膜细胞产生的 IL-1β、MMP-3。
Rheumatol Int. 2013 Jul;33(7):1829-35. doi: 10.1007/s00296-012-2657-0. Epub 2013 Jan 18.
5
Demethylation of MicroRNA-124a Genes Attenuated Proliferation of Rheumatoid Arthritis Derived Fibroblast-Like Synoviocytes and Synthesis of Tumor Necrosis Factor-α.微小RNA-124a基因去甲基化减弱类风湿关节炎来源的成纤维样滑膜细胞的增殖及肿瘤坏死因子-α的合成。
PLoS One. 2016 Nov 8;11(11):e0164207. doi: 10.1371/journal.pone.0164207. eCollection 2016.
6
Kaempferitrin inhibits proliferation, induces apoptosis, and ameliorates inflammation in human rheumatoid arthritis fibroblast-like synoviocytes.山奈酚-3-O-芸香糖苷通过抑制增殖、诱导凋亡和减轻人类风湿关节炎成纤维样滑膜细胞的炎症发挥作用。
Phytother Res. 2019 Jun;33(6):1726-1735. doi: 10.1002/ptr.6364. Epub 2019 Jun 2.
7
Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis.中药青藤碱和梁丘散对肿瘤坏死因子-α激活的类风湿关节炎成纤维样滑膜细胞的抗炎作用。
J Ethnopharmacol. 2011 Sep 1;137(1):457-68. doi: 10.1016/j.jep.2011.05.048. Epub 2011 Jun 6.
8
MLL3 Inhibits Apoptosis of Rheumatoid Arthritis Fibroblast-Like Synoviocytes and Promotes Secretion of Inflammatory Factors by Activating CCL2 and the NF-κB Pathway.MLL3 通过激活 CCL2 和 NF-κB 通路抑制类风湿关节炎成纤维样滑膜细胞凋亡并促进炎症因子分泌。
Inflammation. 2021 Oct;44(5):1803-1814. doi: 10.1007/s10753-021-01459-2. Epub 2021 Apr 29.
9
PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.过氧化物酶体增殖物激活受体γ激动剂罗格列酮通过下调类风湿性关节炎成纤维样滑膜细胞中的Cyr61来抑制迁移和侵袭。
Int J Rheum Dis. 2017 Oct;20(10):1499-1509. doi: 10.1111/1756-185X.12913. Epub 2016 Jul 26.
10
[Effect of Xinfeng Capsules-containing serum on TNF-α-induced apoptosis and inflammation of fibroblast-like synoviocytes in rheumatoid arthritis].[含新风胶囊血清对类风湿关节炎成纤维样滑膜细胞肿瘤坏死因子-α诱导的凋亡及炎症的影响]
Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(2):436-443. doi: 10.19540/j.cnki.cjcmm.20200915.402.

引用本文的文献

1
Bioinspired exosome-SiO nanohybrid therapeutic for rheumatoid arthritis treatment.用于类风湿性关节炎治疗的仿生外泌体-二氧化硅纳米杂化物疗法
Theranostics. 2025 May 30;15(13):6553-6571. doi: 10.7150/thno.108296. eCollection 2025.
2
Locally administered liposomal drug depot enhances rheumatoid arthritis treatment by inhibiting inflammation and promoting cartilage repair.局部给药的脂质体药物贮库通过抑制炎症和促进软骨修复增强类风湿性关节炎的治疗效果。
J Nanobiotechnology. 2025 Jan 31;23(1):69. doi: 10.1186/s12951-025-03110-w.
3
Advances in the use of nanotechnology for treating gout.
纳米技术在痛风治疗中的应用进展。
Nanomedicine (Lond). 2025 Feb;20(4):355-369. doi: 10.1080/17435889.2025.2457315. Epub 2025 Jan 28.
4
Advances in drug delivery systems utilizing blood cells and their membrane-derived microvesicles.利用血细胞及其膜衍生的微小囊泡的药物传递系统的进展。
Drug Deliv. 2024 Dec;31(1):2425156. doi: 10.1080/10717544.2024.2425156. Epub 2024 Nov 8.
5
Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux.巨噬细胞膜功能化的二氧化锰纳米医学通过减轻炎症风暴和促进胆固醇外排来协同治疗动脉粥样硬化。
J Nanobiotechnology. 2024 Oct 28;22(1):664. doi: 10.1186/s12951-024-02939-x.
6
The biomedical applications of nanozymes in orthopaedics based on regulating reactive oxygen species.基于调控活性氧的纳米酶在骨科中的生物医学应用。
J Nanobiotechnology. 2024 Sep 16;22(1):569. doi: 10.1186/s12951-024-02844-3.
7
Progress of Nanomaterials Based on Manganese Dioxide in the Field of Tumor Diagnosis and Therapy.基于二氧化锰的纳米材料在肿瘤诊断和治疗领域的研究进展。
Int J Nanomedicine. 2024 Aug 29;19:8883-8900. doi: 10.2147/IJN.S477026. eCollection 2024.
8
[Advances in the Application of Nanozymes in Joint Disease Therapy].[纳米酶在关节疾病治疗中的应用进展]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jul 20;55(4):800-806. doi: 10.12182/20240760105.
9
Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.纳米技术助力的类风湿关节炎联合治疗:原理、策略与挑战。
J Nanobiotechnology. 2024 Jul 22;22(1):431. doi: 10.1186/s12951-024-02670-7.
10
Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis.基于纳米颗粒清除活性氧的治疗策略在动脉粥样硬化中的进展。
J Nanobiotechnology. 2023 Aug 17;21(1):271. doi: 10.1186/s12951-023-02058-z.